Nėra interneto ryšio – rodoma išsaugota puslapio versija.

CSL Ltd

AUAUD
← Į akcijų filtrą
AU:CSLUS:CMXHF

CSL Ltd (AU:CSL) — Biotechnology. Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 2. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.

Apie įmonę

Svetainė
csl.com.au
Investuotojams
investors.csl.com/
Sektorius
Healthcare · Biotechnology
Būstinė
Melbourne, Australia
Generalinis direktorius
Mr. Gordon Naylor BEng (Hons), C.P.A., DipCompSc, M.B.A.
Darbuotojai
29 000
Įkurta
1994
Apyvartoje esančios akcijos
479.88 mln.
Laisvai apyvartinės akcijos
478.53 mln.
Rinkos kapitalizacija
87.08 mlrd. AUD
Insaideriai
0.02%
Instituciniai investuotojai
38.27%
Aprašymas

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. The company's therapeutic areas includes Immunoglobulins, Immunology, Immunology Haematology, Cardiovascular and Renal, and Vaccines. It also licenses CSL intellectual property. It also develops vaccines for the prevention of infectious disease. The company has strategic collaboration with Dutch biotech company VarmX BV for the development of VMX-C001 to help restore blood coagulation in patients requiring urgent surgery; and Alentis Therapeutics AG to develop and commercialise lixudebart for rare kidney and liver diseases. The company was formerly known as Commonwealth Serum Laboratories Limited and later changed its name to CSL Limited in October 1991. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Biržos ir tikeriai

BiržaTikerisValiutaKainaTipas
AU Australian Securities ExchangeCSL pagrindinisAUD—paprastosios akcijos
US USA StocksCMXHF OTCUSD126.03 -1.29%paprastosios akcijos

Kaina per 3 mėnesius

kilimo diena kritimo diena dividendų ex data išmokėjimo dataUžveskite / palieskite dieną — atidarymo, uždarymo, aukščiausia ir žemiausia kainos

Dividendai

Dividendų išmokų nerasta (patikrinta 09.10.2026). Įmonė greičiausiai nemoka dividendų.

Šios savaitės naujienos

Naujienų iš įmonės svetainės kol kas nėra.

reklama

Didžiausi akcininkai

TurėtojasDalisAkcijosAtaskaitos data
VANGUARD STAR FUNDS-Vang…1.49%7.16 mln.2026-07-31
VANGUARD TAX-MANAGED FUN…0.99%4.75 mln.2026-06-30
iShares Trust-iShares Co…0.75%3.6 mln.2026-08-31
Fidelity Concord Street…0.39%1.89 mln.2026-07-31
iShares Trust-iShares MS…0.36%1.72 mln.2026-08-31
J.P. Morgan Exch-Trd Fd.…0.3%1.45 mln.2026-07-31
Fidelity Salem Street TR…0.29%1.38 mln.2026-07-31
iShares Trust-iShares MS…0.28%1.35 mln.2026-08-31
VANGUARD Intl Eqy. INDEX…0.24%1.16 mln.2026-07-31
SCHWAB STRATEGIC TRUST-S…0.22%1.08 mln.2026-05-31
Pacer Advisors, Inc.0.08%369 7742026-06-30
Naylor (Gordon) (Directo…≈0.01%40 8192026-05-26
McKenzie (Paul F) (Chief…≈0.01%31 0532025-09-01
McNamee (Brian Anthony)…≈0.01%30 5612026-08-21
Linton (Joy) (Chief Fina…≈0%15 0962025-06-30
Watkins (Alison Mary) (I…≈0%6 9892026-08-21
Clark (Megan Elizabeth)…≈0%5 7182025-08-22
Schmeltz (Andy) (Other E…≈0%5 0672025-06-30
Hewson (Carolyn Judith)…≈0%4 1312026-08-21
Price (Cameron Bruce) (I…≈0%3 5592026-08-21
Daniels (Brian M.D.) (No…≈0%3 4002025-11-18